REQUEST FOR EXPRESSION OF INTEREST (REoI) FOR PHARMACEUTICAL PRODUCTS

UNICEF
REQUEST FOR EXPRESSION OF INTEREST (REoI) FOR PHARMACEUTICAL PRODUCTS Request for EOI

Reference: REOI-AFG-2024-002
Beneficiary countries or territories: Multiple destinations (see the Countries or territories tab)
Published on: 12-May-2025
Deadline on: 01-Jun-2026 00:00 (GMT 4.30)

Description

REQUEST FOR EXPRESSION OF INTEREST (REoI)

FOR PHARMACEUTICAL PRODUCTS

REOI-AFG-2024-002

Closing date for receipt of REoI:  Multiple windows of submissions due on 1st day of every month open for 12 month starts on 1st July 2025 and ends on 1st May 2026.

There are multiple due dates for submission: 1st of July 2025, 1st Aug 2025, 1st Sep 2025, 1st Oct 2025, 1st Nov 2025, 1st Dec 2025, 1st Jan 2026, 1st Feb 2026, 1st Mar 2026, 1st April 2026, 1st May 2026 and final due date 1st June 2026.

UNICEF, Afghanistan Country Office, Kabul, Afghanistan is requesting Expressions of Interest from potential suppliers of pharmaceuticals from Afghanistan and its neighbouring countries (India, Iran, Pakistan, China, etc.) in preparation for a solicitation exercise for pharmaceutical products.

Interested suppliers or manufacturers of pharmaceuticals, please read below the requirements and submit your expression of interest (EoI) by filling in the forms along with the documentation requested.

 

Purpose of the REOI:

 

This REoI is addressed to suppliers and manufacturers of pharmaceuticals in the region for the supply of any of the listed pharmaceutical products.

 

Description of requirements:

S.No  Description

1  Aminophylline 100mg tablets

2  Amoxicillin 250mg dispersible tablet

3  Amoxicillin 500mg capsules

4  Amoxicillin 500mg tablets

5  Amoxicillin 125mg/5ml pwd.o.s./BOT-100ml

6  Amoxicillin powder for oral suspension, 250mg /5ml (anhydrous)

7  Ampicillin 1g (as sodium salt) powder for injection

8  Atenolol 100 mg tablets

9  Betamethasone 0.1% + Neomycine 0.5%, topical cream

10  Ceftriaxone powder for injection/infusion 500mg

11  Chlorhexidine 7.1 % umbilical gel tube

12  Chloroquine 50mg/5ml syrup

13  Ciprofloxacin 250mg tablet

14  Compound Sodium Lactate 1L bag

15  Diazepam 5mg/ml, injection

16  Diazepam Diazepam 5mg, tablet

17  Erythromycin (Ethyl succinate) Suspension 100 mg/ml, bottles

18  Ferrous sulphate 60mg tablets

19  Gentamicin eye drops 0.3%

20 Gentamicin 10mg/ml (as sulfate), injection

21  Gentamicin 20mg/ml (as sulfate), injection

22  Hydrocortisone pdr/inj 100mg

23  Iron 60 mg+ Folic Acid 400 mcg/

24  Ketamine 50mg/ml (hydrochloride), injection

25  Lidocaine (hydrochloride) 1% + Adrenaline (epinephrine) 1:200 000, injection

26  Lidocaine (hydrochloride) 2% + Adrenaline (epinephrine) 1:200 000, injection

27  Metronidazole 400mg tablets

28  Micronutrient tabs, used during pregnancy

29  Nitrofurantoin 100mg, tablet

30  ORS fl.1Lx2+ Zinc 20mg 10tabs.kit/PAC

31  ORS low osm. flavour 20.5/1

32  Paracetamol 100mg disp. Tabs

33  Paracetamol 120mg/5ml o.s/BOT-60ml

34  Paracetamol 500mg tabs

35  Phenobarbital 100mg tabs

36  Phenobarbital 200mg/ml

37  Phenobarbital 15mg tabs

38  Phenoxymethylpenicillin (Penicillin V) 500mg (as potassium-salt), tablet

39  Phenoxymethylpenicillin (Penicillin V) 250mg (as potassium-salt), tablet

40  Salbutamol 2mg/5ml oral liquid/BOT-100ml

41  Salbutamol 4mg tablets

42  Salbutamol 5mg/2.5ml Neb sol. amp

43  Salbutamol inhalation (aerosol) 0.1 mg (sulfate) per dose, 200 doses/inhaler

44  Sodium Chloride 0.9 % w/v and Glucose 5% w/v solution

45  Sul.200mg+Trim.40mg/5ml or.sus/BOT-100ml

46  Sulf.100mg+Trimet.20mg disp.tab

47  Sulf.400mg+Trimet.80mg tabs

48  Suxamenthonium inj/50mg/ml/2ml

49  Tetracycline eye ointment 1%/TBE-5g

50  Tramadol 100mg/2ml, injection

51  Zinc 20 mg scored disp. Tablets

 

For an itemised list of products per category, please refer to the accompanying Expression of

Interest (EoI) form.